website logo Closeup of Maryln 2004 rss for marylin's transplant page.com MikeDubrick.com

Google

Search Web

Search Marylin

Donate Your Life Valid XHTML 1.0!

Pharmaceutical Transplant News

Patients Receiving mTOR Inhibitors Exhibit Fewer Early Malignancies Reducing anti-Rejection meds after transplant shows less complications New drug target to fight RA
Arthritis & Rheumatism AtheroGenics To Help Develop Organ Transplant Treatment CytRx Initiates Broad RNAi Program To Develop Novel Therapies For Treating Major Diseases Associated With CMV
Protease-Inhibitor Cocktail Protects, Increases Anti-Microbial Action Of New Peptide CellCept(R) Was Associated With Reduced Incidence Of Cancer, Compared To Azathioprine Inhaled Drug May Aid Lung Transplant Survival
Novartis Marks 20 Years Of Improving Patients' Lives With Innovative Treatments OPTN/UNOS Data Show Newer Transplant Therapies Associated With Lower Cancer Incidence Rates Ganciclovir (Valcyte™/Cymevene®) Reduces Risk Of Cancer In Kidney Transplant Patients
Investigational Drug May Provide New Option For Preventing Transplant Organ Rejection Icoria to Profile Liver Progenitor Stem Cells for Vesta Therapeutics Reducing need for immune suppression for organ transplantation
MAbs to replace ineffective conventional therapies FDA Approves Roche's COBAS AmpliScreen Hepatitis C and HIV-1 Tests To Improve Safety of Organ and Tissue Donations Liver Transplant Patients Gain Same Positive Benefits from CellCept® as Kidney Transplant Patients
New organ transplant drug could reverse some cancers Lung-Transplant patients' long term survival improves with cyclosporine inhalation solution High Levels Of Immunosuppressant May Lead To Tumor Recurrence
List of Canadian Vaccines Made from Aborted Babies Body Parts Boca company acquires transplant antibody Cylex's Immune Function Test, ImmuKnow(R), Identifies Optimal Immune Status for Post-Transplant Therapy and Guides Physicians to Minimize Risk of Infection and Rejection
Sirolimus Reduces The Risk Of Cancer In Kidney Transplant Patients FDA Grants Fast Track Status for ViroPharma's Maribavir for Prevention of Cytomegalovirus Infection New Type of Rejection Blocker Protects Kidneys After Transplant
Immunosuppressant Further Linked To Birth Defects
Transplant News